Advertisement

Topics

LETI Pharma GmbH Company Profile

21:24 EDT 18th June 2018 | BioPortfolio

Laboratorios LETIVor rd. 80 Jahren gründete Prof. Pedro Domingo Sanjuán in Spanien das Experimentallabor für therapeutische Immunologie. LETI steht für: 'Laboratorio Experimental de Terapéutica Immunógena'. Das junge Unternehmen machte sich einen Namen als Pionier bei der Entwicklung von Antibiotika und Impfstoffen. Bereits in den frühen 40er Jahren begann es mit der Entwicklung von Präparaten zur Diagnose und Behandlung von Allergien. Wichtige Schritte auf dem Weg zu Innovationen waren: Die Gründung der Firma C.B.F. (Corporación Biológica Farmacéutica) für Forschung und Entwicklung (1985) und die Einbindung von C.B.F. in nationale Forschungs- und Entwicklungsprogramme sowie in das Eureka-Programm der Europäischen Gemeinschaft (Programmschwerpunkt: ‚Allergy Innovations').
Die Firma C.B.F. wurde später in das Unternehmen Laboratorios LETI S.A. integriert und umbenannt in C.B.F. LETI S.A.. Der Unternehmensverbund LETI mit allen Einzelgesellschaften erwirtschaftete zuletzt einen Jahresumsatz von ca. DM 43 Millionen.

Location

Mannesmannstr. 4
Witten
D-58455
Germany

Contact

Phone: 02302 / 20 28 60
Fax: 02302 / 20 28 620
Email: info@leti.de


News Articles [879 Associated News Articles listed on BioPortfolio]

DGAP-News: Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz

Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz Deutschland/Hexal DGAP-News: Novartis Pharma GmbH / Schlagwort(e): Sonstiges Nov...

Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab

Bad Marienberg - Die Heidelberg Pharma AG (ISIN DE000A11QVV0/ WKN A11QVV) gab heute den Abschluss eines Lizenzvertrags zwischen ihrer Tochtergesellschaft Heidelberg Pharma Research GmbH und der Uni...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 16022018] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Heidelberg Pharma: Lizenz- und Forschungsdeal mit Magenta Therapeutics

Heidelberg Pharma hat mit Magenta Therapeutics eine Kooperation im Bereich der Wirkstoffforschung vereinbart. "Heidelberg Pharma Research GmbH unterzeichnete die Vereinbarung, bei der aus Magentas ...

DGAP-Adhoc: CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich (deutsch)

CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich DGAP-Ad-hoc: CO.DON AG / Schlagwort(e): Markteinführung CO.DON AG: CO.DON AG zeichnet....

Senkron Secures Try 51 M From Gem Global Yield Fund

ISTANBUL, March 2, 2018/PRNewswire/ -- Senkron Güvenlik ve İletişim Sistemleri A.Ş., ("Senkron") has signed a funding facility for TRY 47 million under a Share Read more...

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement

Heidelberg Pharma AG and Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, announced the si...

PubMed Articles [32 Associated PubMed Articles listed on BioPortfolio]

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Moving pharma contracting into the era of accountability.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Clinical Trials [116 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics

A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects

The purpose of this trial is to compare the pharmacokinetic characteristics of two isosorbide -5 -mononitrate extended -release tablets 40 mg of Qilu Pharmaceutical Co., Ltd and ISMO Retar...

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma Gm...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Companies [1246 Associated Companies listed on BioPortfolio]

LETI Pharma GmbH

Laboratorios LETIVor rd. 80 Jahren gründete Prof. Pedro Domingo Sanjuán in Spanien das Experimentallabor für therapeutische Immunologie. LETI steht für: 'Laboratorio Experimental de Terapéutica I...

Leti

CEA is a French research and technology public organisation, with activities in three main areas: energy, technologies for information and healthcare, and defence and security. Wi...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

CEA-Leti

CEA is a French research and technology public organisation, with activities in four main areas: energy, information technologies, healthcare technologies and defence and security...

INJEX Pharma AG

INJEX Pharma Aktiengesellschaft and its subsidiaries INJEX Pharma GmbH and INJEX Vertrieb Deutschland GmbH are specialized in the development, manufacturing and marketing in the m...

More Information about "LETI Pharma GmbH" on BioPortfolio

We have published hundreds of LETI Pharma GmbH news stories on BioPortfolio along with dozens of LETI Pharma GmbH Clinical Trials and PubMed Articles about LETI Pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LETI Pharma GmbH Companies in our database. You can also find out about relevant LETI Pharma GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...


Corporate Database Quicklinks



Searches Linking to this Company Record